Author:
Kang Kai,Xie Fucun,Wu Yijun,Wang Zhile,Wang Li,Long Junyu,Lian Xin,Zhang Fuquan
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference46 articles.
1. Glioblastoma and other malignant gliomas: a clinical review;Omuro;JAMA,2013
2. The 2016 World Health Organization classification of tumors of the central nervous system: a summary;Louis;Acta Neuropathol.,2016
3. Q.T. Ostrom, H. Gittleman, G. Truitt, A. Boscia, C. Kruchko, J.S. Barnholtz-Sloan, CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015, Neuro Oncol. 20(suppl_4) (2018) iv1-iv86.
4. Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma;Wang;J. Exp. Clin. Cancer Res.,2019
5. Challenges and strategies for successful clinical development of immune checkpoint inhibitors in glioblastoma;Majd;Expert Opin. Pharmacother.,2019